IP Library › Patent Application 12425674
Patent Application
App. No. 12/425,674

METHODS OF TREATING NON-PAINFUL BLADDER DISORDERS USING ALPHA2DELTA SUBUNIT CALCIUM CHANNEL MODULATORS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/425,674
Abstract

A method is provided for treatment of non-painful bladder disorders, particularly non-painful overactive bladder without loss of urine. The method comprises administration of an α 2 δ subunit calcium channel modulator, including gabapentin, pregabalin, GABA analogs, fused bicyclic or tricyclic amino acid analogs of gabapentin, amino acid compounds, and other compounds that interact with the α 2 δ calcium channel subunit.

Claims (3)

1 . A method for treating nocturia comprising administering a therapeutically effective amount of an α 2 δ subunit calcium channel modulator selected from the group consisting of Gabapentin and Pregabalin.

2 . A method for treating urinary frequency comprising administering a therapeutically effective amount of an α 2 δ subunit calcium channel modulator selected from the group consisting of Gabapentin and Pregabalin.

3 . A method for treating urinary urgency comprising administering a therapeutically effective amount of an α 2 δ subunit calcium channel modulator selected from the group consisting of Gabapentin and Pregabalin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2010
From: DYNOGEN PHARMACEUTICALS, INC.
To: EDUSA PHARMACEUTICALS, INC.
Reel/Frame 024879/0568 →